Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Alzheimer’s Disease Neuroimaging Initiative; P Hollingworth; R Sims; A Gerrish; D Harold; R Abraham; ML Hamshere; JS Pahwa; V Moskvina; K Dowzell; N Jones; A Stretton; A Richards; D Ivanov; C Widdowson; J Chapman; S Lovestone; J Powell; P Proitsi; MK Lupton; C Brayne; DC Rubinsztein; M Gill; B Lawlor; A Lynch; K Morgan; KS Brown; PA Passmore; D Craig; S Love; PG Kehoe

doi:10.1038/ng.803

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Alzheimer’s Disease Neuroimaging Initiative, P Hollingworth, R Sims, A Gerrish, D Harold, R Abraham, ML Hamshere, JS Pahwa, V Moskvina, K Dowzell, N Jones, A Stretton, A Richards, D Ivanov, C Widdowson, J Chapman, S Lovestone, J Powell, P Proitsi, MK LuptonC Brayne, DC Rubinsztein, M Gill, B Lawlor, A Lynch, K Morgan, KS Brown, PA Passmore, D Craig, S Love, PG Kehoe

Research output: Contribution to journal › Article (Academic Journal) › peer-review

1721 Citations (Scopus)

Abstract

We sought to identify new susceptibility loci for Alzheimer's disease through a staged association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease Genetic Consortium (ADGC) in a companion paper. We undertook a combined analysis of four genome-wide association datasets (stage 1) and identified ten newly associated variants with P ≤ 1 × 10(-5). We tested these variants for association in an independent sample (stage 2). Three SNPs at two loci replicated and showed evidence for association in a further sample (stage 3). Meta-analyses of all data provided compelling evidence that ABCA7 (rs3764650, meta P = 4.5 × 10(-17); including ADGC data, meta P = 5.0 × 10(-21)) and the MS4A gene cluster (rs610932, meta P = 1.8 × 10(-14); including ADGC data, meta P = 1.2 × 10(-16)) are new Alzheimer's disease susceptibility loci. We also found independent evidence for association for three loci reported by the ADGC, which, when combined, showed genome-wide significance: CD2AP (GERAD+, P = 8.0 × 10(-4); including ADGC data, meta P = 8.6 × 10(-9)), CD33 (GERAD+, P = 2.2 × 10(-4); including ADGC data, meta P = 1.6 × 10(-9)) and EPHA1 (GERAD+, P = 3.4 × 10(-4); including ADGC data, meta P = 6.0 × 10(-10)).

Translated title of the contribution	Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Original language	English
Pages (from-to)	429 - 435
Number of pages	7
Journal	Nature Genetics
Volume	43 (5)
Issue number	5
DOIs	https://doi.org/10.1038/ng.803
Publication status	Published - May 2012

Research Groups and Themes

Cerebrovascular and Dementia Research Group

Access to Document

10.1038/ng.803

Handle.net

Persistent link

Cite this

Alzheimer’s Disease Neuroimaging Initiative, Hollingworth, P., Sims, R., Gerrish, A., Harold, D., Abraham, R., Hamshere, ML., Pahwa, JS., Moskvina, V., Dowzell, K., Jones, N., Stretton, A., Richards, A., Ivanov, D., Widdowson, C., Chapman, J., Lovestone, S., Powell, J., Proitsi, P., ... Kehoe, PG. (2012). Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genetics, 43 (5)(5), 429 - 435. https://doi.org/10.1038/ng.803

@article{4445f5fb9032456586065d471bb6673f,

title = "Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease",

abstract = "We sought to identify new susceptibility loci for Alzheimer's disease through a staged association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease Genetic Consortium (ADGC) in a companion paper. We undertook a combined analysis of four genome-wide association datasets (stage 1) and identified ten newly associated variants with P ≤ 1 × 10(-5). We tested these variants for association in an independent sample (stage 2). Three SNPs at two loci replicated and showed evidence for association in a further sample (stage 3). Meta-analyses of all data provided compelling evidence that ABCA7 (rs3764650, meta P = 4.5 × 10(-17); including ADGC data, meta P = 5.0 × 10(-21)) and the MS4A gene cluster (rs610932, meta P = 1.8 × 10(-14); including ADGC data, meta P = 1.2 × 10(-16)) are new Alzheimer's disease susceptibility loci. We also found independent evidence for association for three loci reported by the ADGC, which, when combined, showed genome-wide significance: CD2AP (GERAD+, P = 8.0 × 10(-4); including ADGC data, meta P = 8.6 × 10(-9)), CD33 (GERAD+, P = 2.2 × 10(-4); including ADGC data, meta P = 1.6 × 10(-9)) and EPHA1 (GERAD+, P = 3.4 × 10(-4); including ADGC data, meta P = 6.0 × 10(-10)).",

author = "\{Alzheimer{\textquoteright}s Disease Neuroimaging Initiative\} and P Hollingworth and R Sims and A Gerrish and D Harold and R Abraham and ML Hamshere and JS Pahwa and V Moskvina and K Dowzell and N Jones and A Stretton and A Richards and D Ivanov and C Widdowson and J Chapman and S Lovestone and J Powell and P Proitsi and MK Lupton and C Brayne and DC Rubinsztein and M Gill and B Lawlor and A Lynch and K Morgan and KS Brown and PA Passmore and D Craig and S Love and PG Kehoe",

year = "2012",

month = may,

doi = "10.1038/ng.803",

language = "English",

volume = "43 (5)",

pages = "429 -- 435",

journal = "Nature Genetics",

issn = "1061-4036",

publisher = "Nature Research",

number = "5",

}

Alzheimer’s Disease Neuroimaging Initiative, Hollingworth, P, Sims, R, Gerrish, A, Harold, D, Abraham, R, Hamshere, ML, Pahwa, JS, Moskvina, V, Dowzell, K, Jones, N, Stretton, A, Richards, A, Ivanov, D, Widdowson, C, Chapman, J, Lovestone, S, Powell, J, Proitsi, P, Lupton, MK, Brayne, C, Rubinsztein, DC, Gill, M, Lawlor, B, Lynch, A, Morgan, K, Brown, KS, Passmore, PA, Craig, D, Love, S & Kehoe, PG 2012, 'Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease', Nature Genetics, vol. 43 (5), no. 5, pp. 429 - 435. https://doi.org/10.1038/ng.803

TY - JOUR

T1 - Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

AU - Alzheimer’s Disease Neuroimaging Initiative

AU - Hollingworth, P

AU - Sims, R

AU - Gerrish, A

AU - Harold, D

AU - Abraham, R

AU - Hamshere, ML

AU - Pahwa, JS

AU - Moskvina, V

AU - Dowzell, K

AU - Jones, N

AU - Stretton, A

AU - Richards, A

AU - Ivanov, D

AU - Widdowson, C

AU - Chapman, J

AU - Lovestone, S

AU - Powell, J

AU - Proitsi, P

AU - Lupton, MK

AU - Brayne, C

AU - Rubinsztein, DC

AU - Gill, M

AU - Lawlor, B

AU - Lynch, A

AU - Morgan, K

AU - Brown, KS

AU - Passmore, PA

AU - Craig, D

AU - Love, S

AU - Kehoe, PG

PY - 2012/5

Y1 - 2012/5

N2 - We sought to identify new susceptibility loci for Alzheimer's disease through a staged association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease Genetic Consortium (ADGC) in a companion paper. We undertook a combined analysis of four genome-wide association datasets (stage 1) and identified ten newly associated variants with P ≤ 1 × 10(-5). We tested these variants for association in an independent sample (stage 2). Three SNPs at two loci replicated and showed evidence for association in a further sample (stage 3). Meta-analyses of all data provided compelling evidence that ABCA7 (rs3764650, meta P = 4.5 × 10(-17); including ADGC data, meta P = 5.0 × 10(-21)) and the MS4A gene cluster (rs610932, meta P = 1.8 × 10(-14); including ADGC data, meta P = 1.2 × 10(-16)) are new Alzheimer's disease susceptibility loci. We also found independent evidence for association for three loci reported by the ADGC, which, when combined, showed genome-wide significance: CD2AP (GERAD+, P = 8.0 × 10(-4); including ADGC data, meta P = 8.6 × 10(-9)), CD33 (GERAD+, P = 2.2 × 10(-4); including ADGC data, meta P = 1.6 × 10(-9)) and EPHA1 (GERAD+, P = 3.4 × 10(-4); including ADGC data, meta P = 6.0 × 10(-10)).

AB - We sought to identify new susceptibility loci for Alzheimer's disease through a staged association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease Genetic Consortium (ADGC) in a companion paper. We undertook a combined analysis of four genome-wide association datasets (stage 1) and identified ten newly associated variants with P ≤ 1 × 10(-5). We tested these variants for association in an independent sample (stage 2). Three SNPs at two loci replicated and showed evidence for association in a further sample (stage 3). Meta-analyses of all data provided compelling evidence that ABCA7 (rs3764650, meta P = 4.5 × 10(-17); including ADGC data, meta P = 5.0 × 10(-21)) and the MS4A gene cluster (rs610932, meta P = 1.8 × 10(-14); including ADGC data, meta P = 1.2 × 10(-16)) are new Alzheimer's disease susceptibility loci. We also found independent evidence for association for three loci reported by the ADGC, which, when combined, showed genome-wide significance: CD2AP (GERAD+, P = 8.0 × 10(-4); including ADGC data, meta P = 8.6 × 10(-9)), CD33 (GERAD+, P = 2.2 × 10(-4); including ADGC data, meta P = 1.6 × 10(-9)) and EPHA1 (GERAD+, P = 3.4 × 10(-4); including ADGC data, meta P = 6.0 × 10(-10)).

U2 - 10.1038/ng.803

DO - 10.1038/ng.803

M3 - Article (Academic Journal)

C2 - 21460840

SN - 1061-4036

VL - 43 (5)

SP - 429

EP - 435

JO - Nature Genetics

JF - Nature Genetics

IS - 5

ER -

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Abstract

Research Groups and Themes

Access to Document

Handle.net

Fingerprint

Cite this